Skip to main content
Premium Trial:

Request an Annual Quote

William Franzblau, Randy Berholtz, Byron Hewett


Nanogen has appointed William Franzblau as its vice president of legal affairs. Randy Berholtz, the acting general counsel and secretary, will become senior corporate counsel and senior director of business development. As vice president of legal affairs, Franzblau will be responsible for developing and executing Nanogen’s business plans.

“The goals are to assist the company in the commercialization of the products,” Franzblau said. “I not only bring legal experience but also have business experience, helping put deals together.”

Franzblau comes to Nanogen from Atabok, a digital rights management company for business-to-business communications. From 1993 to 1999, he served as general counsel and chief financial officer of Hemagen Diagnostics. Franzblau received his Masters in Taxation and J.D. degree from Boston University School of Law.


Qiagen of Venlo, the Netherlands, has hired Byron Hewett as senior vice president for sales and marketing and general manager. Hewett will be in charge of the company’s North American sales and marketing operations. These markets represent more than 50 percent of Qiagen’s consolidated net sales, the company said.

Most recently, Hewett was vice president of worldwide marketing for Bayer’s laboratory testing business unit, where he directed global strategic development as well as development and commercialization of new products. Before that he served as head of Bayer’s US laboratory lesting and nucleic acid diagnostics businesses.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.